Financial News
Rapt Therapeutics Inc (NQ: RAPT )
3.750
+0.180
(+5.04%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jul 16, 2024
Add to My Watchlist
All News about Rapt Therapeutics Inc
![](https://ml.globenewswire.com/media/0318fcd4-dd76-410b-9459-4f0b2a1c7b40/small/rapt-therapeutics-logo-color-png.png)
Via GlobeNewswire
![](https://ml.globenewswire.com/media/0318fcd4-dd76-410b-9459-4f0b2a1c7b40/small/rapt-therapeutics-logo-color-png.png)
![](https://ml.globenewswire.com/media/0318fcd4-dd76-410b-9459-4f0b2a1c7b40/small/rapt-therapeutics-logo-color-png.png)
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_1.jpeg?width=1200&height=800&fit=crop)
Recap: RAPT Therapeutics Q3 Earnings
November 13, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_4.png?width=1200&height=800&fit=crop)
Analyst Ratings for RAPT Therapeutics
September 14, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_4.png?width=1200&height=800&fit=crop)
The Latest Analyst Ratings for RAPT Therapeutics
August 09, 2023
Via Benzinga
![](/next-assets/images/schema-image-default.png)
Analyst Ratings for RAPT Therapeutics
June 05, 2023
Via Benzinga
![](https://ml.globenewswire.com/media/0318fcd4-dd76-410b-9459-4f0b2a1c7b40/small/rapt-therapeutics-logo-color-png.png)
![](https://ml.globenewswire.com/media/0318fcd4-dd76-410b-9459-4f0b2a1c7b40/small/rapt-therapeutics-logo-color-png.png)
![](https://ml.globenewswire.com/media/0318fcd4-dd76-410b-9459-4f0b2a1c7b40/small/rapt-therapeutics-logo-color-png.png)
![](/next-assets/images/schema-image-default.png)
Analyst Expectations for RAPT Therapeutics's Future
May 12, 2023
Via Benzinga
![](/next-assets/images/schema-image-default.png)
Recap: RAPT Therapeutics Q1 Earnings
May 11, 2023
Via Benzinga
![](https://ml.globenewswire.com/media/0318fcd4-dd76-410b-9459-4f0b2a1c7b40/small/rapt-therapeutics-logo-color-png.png)
![](https://ml.globenewswire.com/media/0318fcd4-dd76-410b-9459-4f0b2a1c7b40/small/rapt-therapeutics-logo-color-png.png)
![](https://ml.globenewswire.com/media/0318fcd4-dd76-410b-9459-4f0b2a1c7b40/small/rapt-therapeutics-logo-color-png.png)
![](https://investorplace.com/wp-content/uploads/2022/10/biotechnology1600.png)
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_1.png?width=1200&height=800&fit=crop)
Benzinga's Top Ratings Upgrades, Downgrades For September 14, 2023
September 14, 2023
Via Benzinga
![](https://ml.globenewswire.com/media/0318fcd4-dd76-410b-9459-4f0b2a1c7b40/small/rapt-therapeutics-logo-color-png.png)
![](https://ml.globenewswire.com/media/0318fcd4-dd76-410b-9459-4f0b2a1c7b40/small/rapt-therapeutics-logo-color-png.png)
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_0.jpeg?width=1200&height=800&fit=crop)
Benzinga's Top Ratings Upgrades, Downgrades For August 9, 2023
August 09, 2023
Via Benzinga
![](/next-assets/images/schema-image-default.png)
Via Benzinga
![](https://ml.globenewswire.com/media/0318fcd4-dd76-410b-9459-4f0b2a1c7b40/small/rapt-therapeutics-logo-color-png.png)
![](https://ml.globenewswire.com/media/0318fcd4-dd76-410b-9459-4f0b2a1c7b40/small/rapt-therapeutics-logo-color-png.png)
![](https://ml.globenewswire.com/media/0318fcd4-dd76-410b-9459-4f0b2a1c7b40/small/rapt-therapeutics-logo-color-png.png)
![](https://ml.globenewswire.com/media/0318fcd4-dd76-410b-9459-4f0b2a1c7b40/small/rapt-therapeutics-logo-color-png.png)
![](https://ml.globenewswire.com/media/0318fcd4-dd76-410b-9459-4f0b2a1c7b40/small/rapt-therapeutics-logo-color-png.png)
![](https://cdn.benzinga.com/files/images/story/2023/04/17/satsuma_pharmaceuticals_-_logo.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/04/17/marpai_-_logo.jpg?width=1200&height=800&fit=crop)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.